Form 8-K - Current report:
SEC Accession No. 0000950170-22-016075
Filing Date
2022-08-09
Accepted
2022-08-09 16:17:15
Documents
13
Period of Report
2022-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dnay-20220809.htm   iXBRL 8-K 72394
2 EX-99.1 dnay-ex99_1.htm EX-99.1 213931
  Complete submission text file 0000950170-22-016075.txt   421592

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnay-20220809_pre.xml EX-101.PRE 10222
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnay-20220809_lab.xml EX-101.LAB 13896
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnay-20220809.xsd EX-101.SCH 2457
7 EXTRACTED XBRL INSTANCE DOCUMENT dnay-20220809_htm.xml XML 4881
Mailing Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121
Business Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121 858-228-4115
Codex DNA, Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 221148559
SIC: 3826 Laboratory Analytical Instruments